Related Experiment Videos
[Beta blockers in elderly with heart failure]
M Scherillo1, A D'Andrea, M G Tesorio
1Divisione di Cardiologia, Ospedale V. Monaldi, ARNAS, Napoli, Ospedale San Camillo, Roma.
Summary
Beta-blockers are crucial for secondary prevention after myocardial infarction but underused in elderly patients. Studies show potential benefits in reducing cardiac mortality in older adults with heart failure or post-myocardial infarction.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Beta-blocker therapy is vital for secondary prevention post-acute myocardial infarction.
- Underutilization of beta-blockers is noted, especially in elderly populations.
- Limited randomized trials exist for elderly heart failure patients on beta-blockers.
Purpose:
- To review the evidence on beta-blocker utilization and efficacy in elderly patients after acute myocardial infarction and with heart failure.
Summary:
- Previous studies indicate beta-blocker therapy reduced total cardiac mortality by 40% in elderly patients post-myocardial infarction without left ventricular dysfunction.
- A meta-analysis of trials in patients >60 years with heart failure showed a non-significant trend towards reduced total mortality with beta-blockers (OR 0.68).
Impact:
- Highlights the underutilization of beta-blockers in elderly cardiac patients.
- Suggests potential benefits of beta-blockers for mortality reduction in this demographic.
- Underscores the need for further research, particularly randomized trials in elderly heart failure patients.